User talk:Madcowprion

Professor. Oytun ERBAS, MD, PhD. He was born in Ödemiş-TURKEY on 15-11-1978. 2001 Graduated from Ege University Faculty of Medicine. He is a Radiology and Physiology Specialist. He has been doing research in the field of neuroscience since 2010. He was the founder of ERBAS Institute of Experimental Medicine "Illinois-USA & Gebze-TURKEY (2018). His research areas are pharmaceutical R&D, neuroscience, biological psychology. The summary of the results produced in the R&D lab. is given here. OXYTOCIN AND NEURON: In 2011-2013, Effectiveness of oxytocin in the treatment of Parkinson's Disease, Epilepsy and Critical Illness Neuropathy due to sepsis. SICKNESS BEHAVIOR: In 2014, Demonstrated the relationship between inflammation-induced behavioral changes and dopamine release. RESVERATROL AND INFLAMMATION: In 2015, Demonstrated the therapeutic efficacy of resveratrol in the treatment of polycystic ovary syndrome and endometriosis. GLP-1 & ERYTHROPOIETIN AND NEURODEGENERATIVE DISEASES: In 2015, Demonstrated that GLP and EPO reduce brain damage in Alzheimer's and Parkinson's Disease. PREGNANCY & METABOLIC SYNDROME AND AUTISM: In 2018, Demonstrated that the metabolic syndrome during pregnancy causes autism in male infants. SEPSIS and PAPAVERINE: In 2020, Papaverine shows healing effect in sepsis by blocking HMGB1 and RAGE pathway. GLP-1 & ERYTHROPOIETIN AND AUTISM: In 2020, EPO and GLP-1 show a healing effect via IGF-1 in juvenile rats with autism. HYPOXIC ENCEPHALOPATHY AND OXYTOCIN: In 2020, Oxytocin is beneficial in hypoxic encephalopathy in newborn rats. He received the "Politzer Prize" (2013) in the field of Otorhinolaryngology from the International Society of Otological Surgery and the "Jacques Duparc Award" (2013) from the European Orthopedics and Traumatology Association. It has also won dozens of best projects and best oral presentation awards from national congresses. More than 100 scientific articles have been published in journals indexed in international indexes (SCI and SCI-E).